Princeton, NJ · Founded 2019 · Privately Held (backing)
Developer of biopharmaceutical therapies designed to address central nervous system disorders by restoring glutamate homeostasis. iQure Pharma is based in Princeton, NJ and was founded in 2019. Its last reported valuation was $21 million in Nov 2025. It has raised $13.1 million across 4 recorded rounds; the latest was a $650,000 seed round in May 2026.
Last reported valuation
$21.0M
Oct 2026
Priced at
—
Total raised
$13.1M
Last round
Seed Round
May 2026
Team — not yet on record
No current team members for iQure Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of iQure Pharma with a free account
·Watch iQure Pharma: the Monday email on marks, rounds and moves
